PL2485751T3 - GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie - Google Patents

GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie

Info

Publication number: PL2485751T3
Authority: PL; Poland
Prior art keywords: glyx; refractory depression; treating refractory; treating; depression
Prior art date: 2009-10-05

Application number

PL10822514T

Other languages

English (en)

Inventor

Joseph Moskal

Original Assignee

Univ Northwestern

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-05

Filing date

2010-10-05

Publication date

2014-10-31

2010-10-05 Application filed by Univ Northwestern filed Critical Univ Northwestern

2014-10-31 Publication of PL2485751T3 publication Critical patent/PL2485751T3/pl

Links

208000028552 Treatment-Resistant Depressive disease Diseases 0.000 title 1
GIBQQARAXHVEGD-BSOLPCOYSA-N rapastinel Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)N[C@@H]([C@@H](C)O)C(N)=O)CCC1 GIBQQARAXHVEGD-BSOLPCOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Glass Compositions (AREA)
Compositions Of Oxide Ceramics (AREA)
Ceramic Products (AREA)

PL10822514T 2009-10-05 2010-10-05 GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie PL2485751T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24865009P	2009-10-05	2009-10-05
PCT/US2010/051415 WO2011044089A2 (en)	2009-10-05	2010-10-05	Methods of treating depression and other related diseases
EP10822514.5A EP2485751B1 (en)	2009-10-05	2010-10-05	GLYX-13 for use in a method of treating refractory depression

Publications (1)

Publication Number	Publication Date
PL2485751T3 true PL2485751T3 (pl)	2014-10-31

Family

ID=43857351

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL15171991T PL2985032T3 (pl)	2009-10-05	2010-10-05	Glyx do stosowania do leczenia choroby alzheimera, choroby parkinsona lub choroby huntingtona
PL10822514T PL2485751T3 (pl)	2009-10-05	2010-10-05	GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL15171991T PL2985032T3 (pl)	2009-10-05	2010-10-05	Glyx do stosowania do leczenia choroby alzheimera, choroby parkinsona lub choroby huntingtona

Country Status (12)

Country	Link
EP (4)	EP2985032B1 (pl)
CY (1)	CY1118530T1 (pl)
DK (2)	DK2985032T3 (pl)
ES (2)	ES2493316T3 (pl)
HR (1)	HRP20140784T1 (pl)
HU (1)	HUE043807T2 (pl)
PL (2)	PL2985032T3 (pl)
PT (2)	PT2485751E (pl)
RS (1)	RS53513B1 (pl)
SI (1)	SI2485751T1 (pl)
SM (1)	SMT201400117B (pl)
WO (1)	WO2011044089A2 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0918868B8 (pt)	2008-09-18	2021-05-25	Naurex Inc	compostos moduladores do receptor de nmda e composições compreendendo os mesmos
US8951968B2 (en)	2009-10-05	2015-02-10	Northwestern University	Methods of treating depression and other related diseases
WO2011100585A1 (en)	2010-02-11	2011-08-18	Joseph Moskal	Secondary structure stabilized nmda receptor modulators and uses thereof
KR101692275B1 (ko) *	2010-02-11	2017-01-04	노오쓰웨스턴 유니버시티	２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
US9737531B2 (en)	2012-07-12	2017-08-22	Glytech, Llc	Composition and method for treatment of depression and psychosis in humans
US10583138B2 (en)	2012-07-12	2020-03-10	Glytech, Llc	Composition and method for treatment of depression and psychosis in humans
CA2834286A1 (en) *	2011-04-27	2012-11-01	Northwestern University	Methods of treating alzheimer's disease, huntington's disease, autism, and other disorders
AU2013329000A1 (en) *	2012-10-12	2015-04-30	Northwestern University	Methods of identifying compounds for treating depression and other related diseases
JP2016506962A (ja)	2013-01-29	2016-03-07	ノーレックス, インコーポレイテッドNaurex, Inc.	スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用
US9758525B2 (en)	2013-01-29	2017-09-12	Aptinyx Inc.	Spiro-lactam NMDA receptor modulators and uses thereof
KR102410989B1 (ko)	2013-01-29	2022-06-17	앱티닉스 인크.	스피로-락탐 nmda 수용체 조절인자 및 그의 용도
EP2951186B1 (en)	2013-01-29	2018-07-25	Aptinyx Inc.	Spiro-lactam nmda receptor modulators and uses thereof
PE20151416A1 (es)	2013-01-29	2015-10-10	Naurex Inc	Moduladores de receptores nmda de espiro-lactama y sus usos
CN111920412A (zh) *	2013-12-13	2020-11-13	西北大学	治疗脑部病症或鉴定与其相关的生物标记的方法
CN105327349A (zh) *	2014-06-18	2016-02-17	上海翰森生物医药科技有限公司	Nmda受体拮抗剂的医药用途及其药物组合物
AU2015280108B2 (en) *	2014-06-23	2019-11-28	Naurex, Inc.	Methods of treating or ameliorating migraine
JP2017524721A (ja) *	2014-08-14	2017-08-31	ノーレックスインコーポレイテッド	Ｎｍｄａ調節剤を使用するうつ病の治療方法
CN108601814A (zh) *	2015-10-16	2018-09-28	西北大学	用于治疗精神分裂症、双相障碍、认知损害和重度抑郁障碍的非典型抗精神病药和nmda调节剂的药物组合
WO2017189920A1 (en) *	2016-04-28	2017-11-02	The Trustees Of The University Of Pennsylvania	Method of drug design and optimisation utilizing stereochemical mimicry
WO2017201285A1 (en)	2016-05-19	2017-11-23	Aptinyx Inc.	Spiro-lactam nmda receptor modulators and uses thereof
PE20190174A1 (es)	2016-05-19	2019-02-01	Aptinyx Inc	Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
IL286107B2 (en)	2016-08-01	2024-09-01	Aptinyx Inc	Spiro-lactam nmda receptor modulators and usesthereof
WO2018026798A1 (en)	2016-08-01	2018-02-08	Aptinyx Inc.	Spiro-lactam nmda modulators and methods of using same
AU2017306158B2 (en)	2016-08-01	2021-10-14	Aptinyx Inc.	Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
KR102465758B1 (ko)	2016-08-01	2022-11-09	앱티닉스 인크.	스피로-락탐 nmda 수용체 조정제 및 그의 용도
JP7036792B2 (ja)	2016-08-01	2022-03-15	アプティニックスインコーポレイテッド	スピロ－ラクタムｎｍｄａ受容体修飾因子およびその使用
PE20210455A1 (es)	2018-01-31	2021-03-08	Aptinyx Inc	Moduladores del receptor nmda espiro-lactama y usos de los mismos
US12012413B2 (en)	2019-11-11	2024-06-18	Tenacia Biotechnology (Hong Kong) Co., Limited	Methods of treating painful diabetic peripheral neuropathy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4086196A (en)	1975-03-28	1978-04-25	Armour Pharmaceutical Company	Parathyroid hormone
US5763393A (en)	1996-05-17	1998-06-09	Neurotherapeutics L.P.	Neuroactive peptides
AU2002248553A1 (en) *	2001-03-07	2002-09-24	Cognetix, Inc	Linear y-carboxyglutamate rich conotoxins
WO2002072609A2 (en) *	2001-03-12	2002-09-19	Nyxis Neurotherapies, Inc	Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain
EP1660634A4 (en) *	2003-08-08	2009-02-18	Burnham Inst	P16-mediated regulation of NMDA receptors
US20050096311A1 (en) *	2003-10-30	2005-05-05	Cns Response	Compositions and methods for treatment of nervous system disorders

2010
- 2010-10-05 WO PCT/US2010/051415 patent/WO2011044089A2/en not_active Ceased
- 2010-10-05 EP EP15171991.1A patent/EP2985032B1/en active Active
- 2010-10-05 RS RSP20140441 patent/RS53513B1/sr unknown
- 2010-10-05 HR HRP20140784AT patent/HRP20140784T1/hr unknown
- 2010-10-05 PL PL15171991T patent/PL2985032T3/pl unknown
- 2010-10-05 EP EP14169137.8A patent/EP2813236A1/en not_active Withdrawn
- 2010-10-05 ES ES10822514.5T patent/ES2493316T3/es active Active
- 2010-10-05 PT PT108225145T patent/PT2485751E/pt unknown
- 2010-10-05 PL PL10822514T patent/PL2485751T3/pl unknown
- 2010-10-05 HU HUE15171991A patent/HUE043807T2/hu unknown
- 2010-10-05 SI SI201030702T patent/SI2485751T1/sl unknown
- 2010-10-05 ES ES15171991T patent/ES2721448T3/es active Active
- 2010-10-05 DK DK15171991.1T patent/DK2985032T3/en active
- 2010-10-05 DK DK10822514.5T patent/DK2485751T3/da active
- 2010-10-05 PT PT15171991T patent/PT2985032T/pt unknown
- 2010-10-05 EP EP10822514.5A patent/EP2485751B1/en active Active
- 2010-10-05 EP EP18248179.6A patent/EP3488856A1/en not_active Ceased
2014
- 2014-08-13 CY CY20141100649T patent/CY1118530T1/el unknown
- 2014-08-19 SM SM201400117T patent/SMT201400117B/xx unknown

Also Published As

Publication number	Publication date
ES2721448T3 (es)	2019-07-31
SI2485751T1 (sl)	2014-10-30
WO2011044089A2 (en)	2011-04-14
PT2985032T (pt)	2019-04-24
EP3488856A1 (en)	2019-05-29
EP2485751A2 (en)	2012-08-15
DK2985032T3 (en)	2019-04-15
EP2985032B1 (en)	2019-01-02
WO2011044089A3 (en)	2012-02-16
EP2485751B1 (en)	2014-05-21
ES2493316T3 (es)	2014-09-11
HUE043807T2 (hu)	2019-09-30
EP2485751A4 (en)	2013-03-13
EP2813236A1 (en)	2014-12-17
RS53513B1 (sr)	2015-02-27
PL2985032T3 (pl)	2019-07-31
DK2485751T3 (da)	2014-08-18
CY1118530T1 (el)	2017-07-12
EP2985032A1 (en)	2016-02-17
HRP20140784T1 (hr)	2014-10-10
PT2485751E (pt)	2014-09-01
SMT201400117B (it)	2014-11-10

Publication	Publication Date	Title
SI2485751T1 (sl)	2014-10-30	Glyx-13 za uporabo pri postopku za zdravljenje refraktorne depresije
GB0900891D0 (en)	2009-03-04	A unit for and method of treating waste
ZA201200263B (en)	2012-09-26	Compounds and methods for treating influenza
EP2375903A4 (en)	2012-09-19	METHOD FOR TREATING SILENTNESS
IL214919A0 (en)	2011-11-30	Method for therapeutic use
GB0902705D0 (en)	2009-04-01	Surface treatment process for implant
GB0908506D0 (en)	2009-06-24	Method and apparatus for drawing polygons
IL217492A0 (en)	2012-02-29	Treatment method
EP2453896A4 (en)	2013-01-09	PROCESS FOR TREATING SCHIZOPHRENIA
GB2483792B (en)	2012-09-12	Waste treatment method
PL2440642T3 (pl)	2018-03-30	Sposób zmniejszania złych zapachów
EP2260237A4 (en)	2013-11-27	METHOD FOR OPERATING A HIGH FOOD
GB2471907B (en)	2011-11-23	A method of treating diamond
PL2439289T3 (pl)	2017-06-30	Sposób i piec do obróbki cieplnej przedmiotów obrabianych
EP2413698A4 (en)	2013-07-10	PROCESS FOR TREATING OSTEOPOROSIS
PL2336380T3 (pl)	2015-03-31	Sposób i narzędzie do obróbki powierzchni
ZA201200793B (en)	2013-05-29	Composition and process for treatment of a fabric
EP2424539A4 (en)	2012-09-19	PROCESS FOR TREATING DEPRESSION
ZA201200792B (en)	2013-05-29	Composition and process for treatment of a fabric
GB0907249D0 (en)	2009-06-10	New process and new compounds
IL217326A0 (en)	2012-02-29	Method and device for treating substrates
GB0820165D0 (en)	2008-12-10	Process for treatment of materials in a vessel
GB2483039B (en)	2013-07-10	Method for treating hydrocarbons
GB0909083D0 (en)	2009-07-01	Method and apparatus for a game
PL2480714T4 (pl)	2025-07-07	Sposób obróbki powierzchniowej płyt z prasowanego drewna